Georgia CE File Leverage: Reusing Certificates and Technical Conclusions

1. Key takeaways

CE certificates and ISO 13485 certificates can be reused in Georgia. The legal support is Article 2 paragraph 3 and Article 2 paragraph 1 point f of the Law of Georgia No. 6157-Iს on Product Safety and Free Movement of May 8, 2012: products manufactured in conformity with the new approach and global approach directives of the European Union satisfy the essential safety requirements of the code, and conformity assessment is carried out under international and European systems. The boundary of reuse is precise — safety conclusions can be reused, while localisation items must be redone. Everything that expresses a technical judgement about the product travels with the certificate; everything that expresses a commitment to the Georgian market does not.

The economic significance is considerable. A European CE technical file already contains the risk analysis, performance data, and clinical evaluation that a Georgian reviewer needs to see, and ISO 13485 already demonstrates a quality management system at international level. Reusing these assets correctly can remove a large share of dossier preparation work. Reusing them incorrectly — by dumping the entire English file into the submission — creates language and notarisation problems that consume more time than the reuse saved.

The reuse boundary also has a temporal dimension. Certificates and conclusions are reusable only while they remain valid and while the underlying product is unchanged; a renewed CE certificate, a changed notified body, or a modified design can silently invalidate the assumptions of a previous Georgian filing. The reusable-items list should therefore carry validity dates and review triggers, so reuse is re-confirmed at every variation rather than assumed to persist indefinitely.

2. Legal basis

The reuse framework rests on the following provisions.

1. Law of Georgia No. 6157-Iს on Product Safety and Free Movement of May 8, 2012.
2. Article 2 paragraph 1 point f: certification and conformity assessment (CA) are carried out under international and European systems.
3. Article 2 paragraph 1 point d: standardisation gives priority to international and European standards.
4. Article 2 paragraph 3: products manufactured in conformity with the new approach and global approach directives adopted or approved by the European Union satisfy the essential safety requirements of the code.
5. Article 3 paragraph 1: products of states included in the list and manufactured under their domestic law may be placed on the market without restriction; the country list is determined by the Government of Georgia.
6. Law of Georgia on Drugs and Pharmaceutical Activity, Law No. 1586 of August 10, 2009, Article 11⁷: the recognition regime relies on same-product identification documents.

The interaction of the two statutes is what makes the Georgian system unusually receptive to European documentation: the Product Safety code supplies the acceptance of European conformity, while Article 11⁷ of the drug law supplies the recognition channel that consumes the same sameness evidence. A manufacturer holding a complete CE file is therefore positioned for both regimes at once.

3. Expert insights

Insight 1: Article 2 paragraph 1 point f is the legal source for accepting ISO 13485. The provision requires conformity assessment to be carried out under international and European systems, and ISO 13485 is precisely the quality management system standard of the international system. When submitting QMS evidence, manufacturers should cite this provision to explain why the certificate is acceptable, rather than simply attaching the certificate and letting the reviewer make the connection. A one-paragraph legal note attached to the certificate raises the probability of a first-pass acceptance materially.

Insight 2: what is reused is the conclusion, not the document. The legal effect of manufacturing in conformity with the European directives is a presumption that the essential safety requirements are satisfied — a presumption about the conclusion of the assessment. CE technical file conclusions may therefore be cited directly, but the citation form is conclusion plus evidence index, not the wholesale submission of the English original. Submitting the entire file triggers language and notarisation issues and slows the process down, which defeats the purpose of reuse entirely.

Insight 3: the country list under Article 3 paragraph 1 is an accelerator for reuse. Where the country of origin appears on the government list, products manufactured under its domestic law may be placed on the market without restriction in regulated areas. Verifying that the country of origin is listed — and archiving the list version and the date of the check — converts the CE advantage into a concrete facilitation step. Many manufacturers overlook this verification and end up repeating certification work that the list would have made unnecessary.

4. Practical recommendations

The following practices turn certificate reuse into a repeatable routine, with re-verification triggers built in.

1. Maintain a reusable-items list: safety conclusions, performance data, clinical evaluation, and risk analysis conclusions may be cited; labels, instructions for use, local representative information, and application forms must be redone for the Georgian market.
2. Cite CE documentation in a three-part form — conclusion, evidence index, and source annex — so the reviewer can trace every reused conclusion to its original evidence without receiving the full English file.
3. Verify whether the country of origin appears on the government list, and archive the list version and the verification date as supporting evidence for the market-access file.
4. Attach a short legal explanation referencing Article 2 paragraph 1 point f whenever the ISO 13485 certificate is submitted, so the acceptance of the certificate rests on the statutory basis rather than on reviewer discretion.
5. Re-verify the reusable-items list whenever the CE certificate is renewed, the notified body changes, or a design modification is released, and record the re-verification in the project file.

5. Verification checklist

• □ Reusable-items list established, separating conclusions from localisation items
• □ CE documentation cited in the three-part form
• □ Country-of-origin list verified and archived
• □ ISO 13485 submission accompanied by the legal explanation
• □ Georgian-language labels and instructions for use redone

Regulatory information verified as of October 30, 2026

This English version was prepared by GRZAN for the international medical device registration guide. GRZAN provides regulatory translation, dossier preparation and market-entry support for Georgia and other jurisdictions. Questions about this article may be sent to info@grzanglobal.com.